TABLE 2.
Spearman’s r (P-value) | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
apoETX | apoEFA | Aβ40 TX | Aβ40FA | Aβ42 TBS | Aβ42 TX | Aβ42FA | T-tau TBS | T-tau TX | T-tau FA | p-tau TBS | p-tau TX | p-tau FA | CLDN5 TX | OCLN TX | ||
ApoE TBS |
0.45 (<0.001) | 0.01 (0.85) | −0.07 (0.11) | −0.06 (0.19) | −0.15 (0.002) | 0.14 (0.003) | 0.01 (0.76) | −0.09 (0.046) | 0.26 (<0.001) | 0.23 (<0.001) | 0.18 (<0.001) | 0.26 (<0.001) | −0.04 (0.38) | −0.01 (0.83) | −0.29 (<0.001) | −0.26 (<0.001) |
TX | 1.00 | 0.27 (<0.001) | 0.12 (0.011) | 0.33 (<.0001) | 0.03 (0.58) | −0.12 (0.008) | 0.01 (0.77) | −0.07 (0.15) | 0.34 (<0.001) | 0.01 (0.87) | −0.15 (0.001) | 0.04 (0.44) | −0.13 (0.004) | −0.07 (0.15) | −0.18 (<0.001) | −0.31 (<0.001) |
FA | - | 1.00 | 0.31 (<0.001) | 0.37 (<0.001) | 0.48 (<0.001) | 0.07 (0.11) | 0.08 (0.068) | 0.08 (0.095) | −0.10 (0.027) | −0.18 (<0.001) | 0.24 (<0.001) | 0.01 (0.72) | 0.29 (<0.001) | 0.45 (<0.001) | −0.17 (<0.001) | −0.06 (0.21) |
Aβ40 TBS |
- | - | 1.00 | 0.52 (<0.001) | 0.63 (<0.001) | 0.29 (<0.001) | 0.22 (<0.001) | 0.15 (0.001) | 0.06 (0.17) | 0.08 (0.100) | 0.07 (0.13) | −0.06 (0.16) | 0.00 (0.99) | 0.09 (0.059) | −0.04 (0.35) | 0.01 (0.83) |
TX | - | - | - | 1.00 | 0.55 (<0.001) | 0.13 (0.004) | 0.25 (<0.001) | 0.07 (0.15) | 0.03 (0.51) | −0.04 (0.44) | −0.08 (0.069) | −0.04 (0.38) | 0.04 (0.40) | 0.05 (0.30) | −0.04 (0.41) | −0.10 (0.030) |
FA | - | - | - | - | 1.00 | 0.21 (<0.001) | 0.19 (<0.001) | 0.23 (<0.001) | −0.12 (0.009) | −0.06 (0.22) | 0.12 (0.013) | −0.07 (0.13) | 0.21 (<0.001) | 0.25 (<0.001) | 0.02 (0.72) | 0.09 (0.042) |
Aβ42 TBS |
- | - | - | - | - | 1.00 | 0.66 (<0.001) | 0.41 (<0.001) | 0.23 (<0.001) | 0.44 (<0.001) | 0.39 (<0.001) | 0.34 (<0.001) | 0.11 (0.022) | 0.19 (<0.001) | −0.17 (<0.001) | 0.18 (<0.001) |
TX | - | - | - | - | - | - | 1.00 | 0.53 (<0.001) | 0.20 (<0.001) | 0.39 (<0.001) | 0.29 (<0.001) | 0.27 (<0.001) | 0.22 (<0.001) | 0.17 (<0.001) | −0.05 (0.31) | 0.26 (<0.001) |
FA | - | - | - | - | - | - | - | 1.00 | 0.05 (0.25) | 0.18 (<0.001) | 0.22 (<0.001) | 0.08 (0.10) | 0.21 (<0.001) | 0.17 (<0.001) | 0.04 (0.40) | 0.32 (<0.001) |
T-tau TBS |
- | - | - | - | - | - | - | - | 1.00 | 0.60 (<0.001) | 0.07 (0.14) | 0.09 (0.045) | −0.21 (<0.001) | −0.38 (<0.001) | −0.26 (<0.001) | −0.15 (0.001) |
TX | - | - | - | - | - | - | - | - | - | 1.00 | 0.29 (<0.001) | 0.16 (<0.001) | −0.54 (<0.001) | −0.29 (<0.001) | −0.18 (<0.001) | 0.17 (<0.001) |
FA | - | - | - | - | - | - | - | - | - | - | 1.00 | 0.14 (0.002) | 0.14 (0.002) | 0.39 (<0.001) | −0.13 (0.005) | 0.18 (<0.001) |
p-Tau TBS |
- | - | - | - | - | - | - | - | - | - | - | 1.00 | 0.24 (<0.001) | 0.03 (0.45) | −0.03 (0.49) | 0.15 (<0.001) |
TX | - | - | - | - | - | - | - | - | - | - | - | - | 1.00 | 0.61 (<0.001) | 0.07 (0.15) | 0.24 (<0.001) |
FA | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.00 | −0.15 (0.002) | 0.06 (0.19) |
CLDN5 TX |
1.00 | 0.48 (<0.001) | ||||||||||||||
OCLN TX |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.00 |
P-values <.05 were considered statistically significant in this exploratory correlation analysis; statistically significant correlations are shown in bold.
Abbreviation: APOE, apolipoprotein E; CAA, cerebral amyloid angiopathy; FA, formic acid; TBS, Tris-buffered saline; TX, 1% Triton X-100